SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotransplant(BTRN)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
1475 39 0 BTRN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1275Protein Design Labs Begins Phase II Trial of Nuvion(TM) In Steroid-Refractory Grnigel bates-3/11/2002
1274Another block trade of 30,000 today..also, BioTransplant Incorporated's 2001Arthur Radley-3/8/2002
1273IMO we are seeing some firming and support for the stock. The stock was bid/ask Arthur Radley-3/6/2002
1272Appears now that even China is catching up and maybe passing all with their stemArthur Radley-3/6/2002
1271As the old saying goes..."Where there is smoke, there is a fire!" WellArthur Radley-3/5/2002
1270Volume is up. Usually a good sign. If I had not already loaded up, I would buy tseminole-3/5/2002
1269>> why bother with this trial << There are still organs that are loscaram(o)uche-3/5/2002
1268I agree....I get an email it seems every day from this outfit. Appears they are Arthur Radley-3/5/2002
1267<i>while also potentially providing a unique complementary therapy to immuscaram(o)uche-3/5/2002
1266AtheroGenics Commences Phase I Trial for Novel Drug AGI-1096 For the Prevention Arthur Radley-3/5/2002
1265Interesting article on Japan's effort with stem-cell research. Seems they arArthur Radley-3/4/2002
1264For those who use TA for their investing, the OBV for BTRN is very positive whenArthur Radley-3/2/2002
1263Would suggest reading the complete news release on the company website....http:/Arthur Radley-2/27/2002
1262BOSTON--(BW HealthWire)--Feb. 27, 2002-- Scientists at Immerge BioTherapeutics Inigel bates-2/27/2002
1261Since they had this session at 7:30 a.m. today, I wonder why we had no news releArthur Radley-2/26/2002
1260I thought MEDI was to release new data today at the AAD conference.Arthur Radley-2/26/2002
1259Isis Icam antisense compound in psoriasis biz.yahoo.com Monday February 25, 2:Biotech Jim-2/25/2002
1258OTHER PSORIASIS DRUGS At AAD: MEDI-507, ABX-IL8, And ISIS 2302 MedImmunaknahow-2/25/2002
1257rec'd from a friend (thanks, J!) who can't post here..... Journal of Viscaram(o)uche-2/24/2002
1256PASI 75 isn't clearance, and not all patients are hitting that goal. 1. Thscaram(o)uche-2/23/2002
1255Rick--What's your assessment of Enbrel and Remicade for psoriasis? Looks imJOEBT1-2/23/2002
1254Our Problem Also... Friday February 22, 1:55 pm Eastern Time Xoma Shares Slide aArthur Radley-2/22/2002
1253Yes! It has turned around, but opened down this morning...wish they would releasArthur Radley-2/22/2002
1252<i>I think maybe we are getting some down draft today from the news with Ejayhawk969-2/22/2002
1251JD, Wish I could...but I bought earlier and higher....(:<<) Well! I boughArthur Radley-2/22/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News